Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-12-29: Form 6-K; Period of report 2017-12-29; Description 6-K; Document d505663d6k.htm.
- 2017-12-29: Form 6-K; Period of report 2017-12-29; Description 6-K; Document d516241d6k.htm.
- 2017-12-20: Form 6-K; Period of report 2017-12-20; Description FORM 6-K; Document d473870d6k.htm.
- 2017-12-14: Form 6-K; Period of report 2017-12-14; Description FORM 6-K; Document d513260d6k.htm.